Market Overview

Akorn Acquires Betimol® from Santen

Share:

Akorn (NASDAQ: AKRX)
today announced that it has acquired the NDA and all rights to Betimol®
(timolol ophthalmic solution) 0.25% & 0.5% from Santen. Akorn plans to
begin shipping Betimol® in the first quarter of 2014.

See full press release

Posted-In: News Guidance Financing Contracts Legal Management M&A Global

 

Related Articles (AKRX)

View Comments and Join the Discussion!